Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Evolent Health Q3 Adj. EPS $0.05 Misses $0.11 Estimate, Sales $479.533M Beat $473.745M Estimate

Author: Benzinga Newsdesk | November 06, 2025 04:12pm
Evolent Health (NYSE:EVH) reported quarterly earnings of $0.05 per share which missed the analyst consensus estimate of $0.11 by 53.27 percent. This is a 25 percent increase over earnings of $0.04 per share from the same period last year. The company reported quarterly sales of $479.533 million which beat the analyst consensus estimate of $473.745 million by 1.22 percent. This is a 22.83 percent decrease over sales of $621.401 million the same period last year.

Posted In: EVH

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist